Oncotype DX in BRCA-associated vs. sporadic breast cancers: Differences based on germline mutation status and potential implications for adjuvant systemic therapy (AST) Meeting Abstract


Authors: Shah, P. D.; Patil, S.; Dickler, M. N.; Offit, K.; Hudis, C. A.; Robson, M. E.
Abstract Title: Oncotype DX in BRCA-associated vs. sporadic breast cancers: Differences based on germline mutation status and potential implications for adjuvant systemic therapy (AST)
Meeting Title: 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036901126
PROVIDER: wos
Notes: Meeting Abstract: 519 -- Source: Wos
MSK Authors
  1. Sujata Patil
    365 Patil
  2. Kenneth Offit
    494 Offit
  3. Clifford Hudis
    818 Hudis
  4. Mark E Robson
    358 Robson
  5. Maura N Dickler
    234 Dickler
  6. Payal Deepak Shah
    15 Shah